Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract

Phytotherapy Research

Volumn 22, Issue 3, 2008, Pages 323-329

  Choi, Soo Youn ^a   Jung, Sung Hoon ^a   Lee, Hyun Sun ^a   Park, Kwen Woo ^a   Yun, Bong Sik ^b   Lee, Kwang Won ^a  

^a Korea University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Advanded glycation end products; Antioxidant; Maillard reaction; Plantago asiatica; Plantamajoside

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; PLANT EXTRACT; PLANTAGO ASIATICA EXTRACT; PLANTAMAJOSIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; COUGHING; DRUG ACTIVITY; DRUG IDENTIFICATION; FEVER; FLUORESCENCE; GLYCATION; IN VITRO STUDY; MEDICINAL PLANT; PLANTAGO ASIATICA; TRADITIONAL MEDICINE; WOUND;

ANTIOXIDANTS; ASCORBIC ACID; CATECHOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; PHENOLS; PICRATES; PLANT EXTRACTS; PLANTAGO;

PLANTAGO ASIATICA;

EID: 40849085255     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2316     Document Type: Article

References (29)

1. Ahmed N. 2005. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21.
2. Bolton WK, Cattran DC, Williams ME et al. 2004. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 24: 32-40.
3. Bucala R, Cerami A. 1992. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23: 1-34.
4. Catterall F, Souquet J-M, Cheynier V, Clifford MN, Ioannides C. 2000. Modulation of the mutagenicity of food carcinogens by oligomeric and polymeric procyanidins isolated from grape seeds: synergistic genotoxicity with N- nitrosopyrrolidine. J Sci Food Agric 80: 91-101.
5. Chiang LC, Chiang W, Chang MY, Lin CC. 2003. In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. Am J Chin Med 31: 225-234.
6. Fenglin H, Ruili L, Bao H, Liang M. 2004. Free radical scavenging activity of extracts prepared from fresh leaves of selected Chinese medical plants. Fitoterapia 75: 14-23.
7. Finot PA. 2005. Historical perspective of the Maillard reaction in food science. Ann NY Acad Sci 1043: 1-8.
8. Jakus V, Rietbrock N. 2004. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53: 131-142.
9. Jiménez-Escrig A, Jiménez-Jiménez I, Pulido R, Saura-Calixto F. 2001. Antioxidant activity of fresh and processed edible seaweeds. J Sci Food Agric 81: 530-534.
10. Kim HY, Kim K. 2003. Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro. J Agric Food Chem 51: 1586-1591
11. Kim SH, Kim SA, Park MK et al. 2004. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. Int Immunopharmacol 4: 279-287.
12. Komoda Y, Chujo H, Ishihara S, Uchida M. 1989. HPLC quantitative analysis of plantaginin in Shazenso (Plantago asiatica L.) extracts and isolation of plantamajoside. Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku 23: 81-85.
13. Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. 2005. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull 28: 1639-1644.
14. Lee KW, Simpson G, Ortwerth B. 1999. A systematic approach to evaluate the modification of lens proteins by glycation-induced crosslinking. Biochim Biophys Acta 1453: 141-151.
15. Lin CC, Kan WS. 1990. Medicinal plants used for the treatment of hepatitis in Taiwan. Am J Chin Med 18: 35-43.
16. Löpez MG, Feather MS. 1992. The production of threose as a degradation product from L-ascorbic acid. J Carbohydr Chem 11: 799-806.
17. Maillard LC. 1912. Action of amino acids on sugars. Formation of melanoidins in a methodical way. Compt Rend 154: 66-68.
18. Munch G, Thome J, Foley P, Schinzel R, Riederer P. 1997. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res 23: 134-143.
19. Nishibe S. 2002. The plant origins of herbal medicines and their quality evaluation, Yakugaku Zasshi 122: 363-379.
20. O'Brien J, Morrissey PA. 1989. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr 28: 211-248.
21. Rajbar S. 1968. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 22: 296-298.
22. Ravn H, Nishibe S, Sasahara M, Xuebo L. 1990. Phenolic compounds from Plantago asiatica. Phytochemistry 29: 3627-3631.
23. Reddy VP, Beyaz A. 2006. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today 11: 646-654.
24. Sell DR, Nelson JF, Monnie VM. 2001. Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat. J Gerontol A Biol Sci Med Sci 56: B405-B411.
25. Singleton VL, Rossi JA. 1965. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Viticult 16: 144-158.
26. Takahashi M, Kushida K, Ohishi T et al. 1994. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 37: 724-728.
27. Teissedre PL, Frankel EN, Waterhouse AL, Peleg H, German JB. 1996. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J Sci Food Agric 70: 55-61.
28. Thorpe SR, Baynes JW. 2003. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25: 275-281.
29. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. 2005. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci 1043: 461-466.